Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants.

International journal of oncology

Volumn 15, Issue 5, 1999, Pages 955-959

  Ulsperger, E ^a   Hamilton, G ^a   Raderer, M ^a   Baumgartner, G ^a   Hejna, M ^a   Hoffmann, O ^a   Mallinger, R ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; ESTROGEN; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PLANT MEDICINAL PRODUCT; RESVERATROL; STILBENE DERIVATIVE; TAMOXIFEN;

ARTICLE; BREAST TUMOR; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LUNG; MALE; OSTEOBLAST; PANCREAS TUMOR; PROSTATE TUMOR;

ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CARCINOMA, RENAL CELL; CELL DIFFERENTIATION; CELL LINE; CULTURE MEDIA, CONDITIONED; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; ISOFLAVONES; KIDNEY NEOPLASMS; LUNG; MALE; OSTEOBLASTS; PANCREATIC NEOPLASMS; PHYTOESTROGENS; PLANT PREPARATIONS; PROSTATIC NEOPLASMS; STILBENES; TAMOXIFEN; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0033228453     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.15.5.955     Document Type: Article

References (0)